Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001234066-04-000015

President and CEO sold 10,000 shares at $9.69 ($96,900)

  • President and CEO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HARRIS ROBERT B · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2004-04-05 Exercise or conversion : show line 1 in the form +10,000 $3.85 $38,500 61,121 D
2004-04-05 Sale : show line 2 in the form −10,000 $9.69 $96,900 51,121 D
Open-market sales · 10,000 sh · avg $9.69 · $96,900

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2004-04-05 Exercise or conversion : show line 3 in the form Options −10,000 109,460 D
Loading xslF345X02/primary_doc.xml…